Press Releases & Updates
September 05, 2023
Advantx Pharmaceuticals Selected to Present it’s World-Class Sigma Platform at PAINWeek
Advantx Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing advanced disease-modifying therapies based on Sigma receptors, announced today that it has been selected to present at the prestigious PAINWeek conference, September 5th – 8th in Las Vegas. This will be the company’s first time showcasing their platform to the U.S. Conference Community, after presenting at Roma Pain Days in Italy and other various conferences in Mexico and Tunisia.
More Info: 230905 Advantx PAINWeek